Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Cushing Syndrome × Dabigatran × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 4 Venous Thrombosis 2 Venous Thromboembolism 2 Pulmonary Embolism 2 Thrombosis 1 Prostatic Neoplasms 1 Myeloproliferative Disorders 1 Cushing Syndrome 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Advanced Non-small Cell Lung Cancer 1

Interventions

relacorilant 5 Mifepristone 3 Corlux 3 pembrolizumab 1 Osilodrostat 1 Dabigatran 1 Continuous Glucose Monitoring 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05347979 2023-02-09

Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants

Corcept Therapeutics

Phase 1 Completed

Cushing Syndrome, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡